Angela R.
- Country
- Germany
- Department
- Klinik für Neurologie Universitäts- und Rehabilitationskliniken Ulm
Research Overview
- Efficacy and Safety of Surlorian in Adults with Autosomal Dominant RYR1-Related Myopathy: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
- C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)
- Evaluation of Nipocalimab Efficacy and Safety in Adults with Seropositive Generalized Myasthenia Gravis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 89 of 197 partner sites.
Specializations
Inflammatory Myopathies
This investigator specializes in studying novel treatments for idiopathic inflammatory myopathy (IIM) and dermatomyositis, focusing on innovative therapeutic approaches using subcutaneous formulations.
- Efgartigimod PH20 SC evaluation
- IgPro20 therapeutic applications
- Immunomodulatory therapy optimization
Particular attention is given to long-term safety profiles and clinical improvement metrics in adult patients with active disease states.
Muscular Dystrophy Research
The investigator conducts extensive research in facioscapulohumeral muscular dystrophy (FSHD), with a focus on both innovative therapeutic compounds and disease progression assessment.
- ARO-DUX4 development
- Losmapimod treatment evaluation
- FSHD disease progression markers
Research encompasses both short-term efficacy measures and extended safety monitoring protocols for muscular dystrophy treatments.
Clinical Assessment Methods
The investigator employs advanced clinical assessment techniques focusing on quantitative measurement systems and comprehensive response evaluation.
- Total Improvement Score (TIS) assessment
- RWS quantification protocols
- Pharmacodynamic evaluation methods
Emphasis is placed on developing reliable metrics for measuring therapeutic responses in neuromuscular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.